SCHEMBL6409773

SCHEMBL6409773

CCCC(=O)N1CCC2(CC1)CC(OC(=O)Nc1ccccc1)=NO2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.42
USP2 O75604 1/20 0.42
CYP2C19 P33261 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
JAK2 O60674 1/20 0.40
JAK1 P23458 1/20 0.40
TSHR P16473 1/20 0.39
NAMPT P43490 2/20 0.39
CYP3A4 P08684 1/20 0.38
OPRM1 P35372 1/20 0.38
OPRL1 P41146 1/20 0.38
RAB9A P51151 1/20 0.37
POLB P06746 1/20 0.37
LMNA P02545 1/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
TRPM8 Q7Z2W7 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2584142 0.82 MAPT (0.49) MAPTUSP2CYP2C19CYP1A2CYP2D6
SCHEMBL6410146 0.79 TSHR (0.43) USP2CYP1A2TSHRNAMPTCYP3A4
SCHEMBL6409565 0.77 GAA (0.41) JAK2JAK1CYP3A4RAB9ASMN1; SMN2
SCHEMBL6419550 0.73 RAB9A (0.54) MAPTUSP2CYP2C19CYP1A2CYP2C9
SCHEMBL6410103 0.73 CYP2D6 (0.42) MAPTCYP2D6MAPK1
SCHEMBL6411980 0.73 EPHX1 (0.37)
SCHEMBL6411868 0.72 NPC1 (0.46) MAPTTSHRRAB9APOLBMAPK1
SCHEMBL2400832 0.72 GPR119 (0.37) MAPTUSP2JAK2JAK1NAMPT
SCHEMBL6410969 0.72 GRM5 (0.45) POLB
SCHEMBL6409532 0.71 CYP2D6 (0.40) USP2CYP2C19CYP1A2CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1401841-B1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN GRUENENTHAL GMBH (DE) 2005-08-24 EP claimed
EP-1401841-A1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN Grünenthal GmbH (DE) 2004-03-31 EP claimed
WO-2003000699-A1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO[4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN Grünenthal GmbH (DE) 2003-01-03 WO claimed
EP-1401841-B1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN GRUENENTHAL GMBH (DE) 2005-08-24 EP disclosed
EP-1401841-A1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO 4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN Grünenthal GmbH (DE) 2004-03-31 EP disclosed
WO-2003000699-A1 SUBSTITUTED 1-OXA-2,8-DIAZA-SPIRO[4,5]DEC-2-ENE DERIVATIVES AS MEDICAMENTS FOR THE TREATMENT OF PAIN Grünenthal GmbH (DE) 2003-01-03 WO disclosed